Cargando…

The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis

The understanding of HIV-1 pathogenesis and clinical progression is incomplete due to the variable contribution of host, immune, and viral factors. The involvement of viral factors has been investigated in extreme clinical phenotypes from rapid progressors to long-term non-progressors (LTNPs). Among...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Yanes, Silvia, Pernas, María, Marfil, Silvia, Cabrera-Rodríguez, Romina, Ortiz, Raquel, Urrea, Víctor, Rovirosa, Carla, Estévez-Herrera, Judith, Olivares, Isabel, Casado, Concepción, Lopez-Galindez, Cecilio, Blanco, Julià, Valenzuela-Fernández, Agustín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988142/ https://www.ncbi.nlm.nih.gov/pubmed/35401460 http://dx.doi.org/10.3389/fmicb.2022.763039

Ejemplares similares

Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression
por: Valenzuela-Fernández, Agustín, et al.
Publicado: (2022)

HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic
por: Cabrera-Rodríguez, Romina, et al.
Publicado: (2019)

Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers
por: Casado, Concepción, et al.
Publicado: (2018)

Zika Virus Pathogenesis: A Battle for Immune Evasion
por: Estévez-Herrera, Judith, et al.
Publicado: (2021)

The Interplay of HIV and Autophagy in Early Infection
por: Cabrera-Rodríguez, Romina, et al.
Publicado: (2021)

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity
por: Pernas, Maria, et al.
Publicado: (2015)

Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control
por: Moyano, Ana, et al.
Publicado: (2022)

TDP-43 Controls HIV-1 Viral Production and Virus Infectiveness
por: Cabrera-Rodríguez, Romina, et al.
Publicado: (2023)

HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton
por: Cabrera-Rodríguez, Romina, et al.
Publicado: (2023)

Initial Fitness Recovery of HIV-1 Is Associated with Quasispecies Heterogeneity and Can Occur without Modifications in the Consensus Sequence
por: Bordería, Antonio V., et al.
Publicado: (2010)

HIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection
por: Marrero-Hernández, Sara, et al.
Publicado: (2019)

Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6
por: Cabrera-Rodríguez, Romina, et al.
Publicado: (2022)

Retroviral Env Glycoprotein Trafficking and Incorporation into Virions
por: Murakami, Tsutomu
Publicado: (2012)

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure
por: Casado, Concepcion, et al.
Publicado: (2020)

The HIV Env Glycoprotein Conformational States on Cells and Viruses
por: Zhao, Connie, et al.
Publicado: (2022)

Exploiting glycan topography for computational design of Env glycoprotein antigenicity
por: Yu, Wen-Han, et al.
Publicado: (2018)

Identification of a Cluster of HIV-1 Controllers Infected with Low Replicating Viruses
por: Casado, Concepción, et al.
Publicado: (2013)

Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
por: Curriu, Marta, et al.
Publicado: (2012)

Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
por: Pradenas, Edwards, et al.
Publicado: (2021)

Envés
por: Amara, Luigi, 1971-
Publicado: (2003)

Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection
por: Vzorov, Andrei N, et al.
Publicado: (2007)

Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors
por: Colomer-Lluch, Marta, et al.
Publicado: (2022)

Mutations of the Rous sarcoma virus env gene that affect the transport and subcellular location of the glycoprotein products
Publicado: (1984)

Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer
por: Sarkar, Anita, et al.
Publicado: (2018)

Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller
por: Pernas, María, et al.
Publicado: (2012)

HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity
por: Serena, Michela, et al.
Publicado: (2017)

Identification of the hASCT2-binding domain of the Env ERVWE1/syncytin-1 fusogenic glycoprotein
por: Cheynet, Valérie, et al.
Publicado: (2006)

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization
por: Pradenas, Edwards, et al.
Publicado: (2023)

Corrigendum: HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity
por: Serena, Michela, et al.
Publicado: (2018)

Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
por: Valenzuela-Fernández, Agustín, et al.
Publicado: (2022)

A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity
por: González-Feliciano, José A., et al.
Publicado: (2020)

Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression
por: Casado, Concepción, et al.
Publicado: (2010)

Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
por: Aguilar-Gurrieri, Carmen, et al.
Publicado: (2023)

Generation of H9 T-cells stably expressing a membrane-bound form of the cytoplasmic tail of the Env-glycoprotein: lack of transcomplementation of defective HIV-1 virions encoding C-terminally truncated Env
por: Holtkotte, Denise, et al.
Publicado: (2006)

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
por: Pradenas, Edwards, et al.
Publicado: (2022)

The roles of ebolavirus glycoproteins in viral pathogenesis
por: Ning, Yun-Jia, et al.
Publicado: (2016)

Maternal intranasal immunization with HTLV-1 Env induces Env specific antibody responses in breast milk
por: Suzuki, Tadaki
Publicado: (2015)

A Bayesian network approach to study host and viral genetic correlates of HIV-1 disease progression
por: Snoek, Joke, et al.
Publicado: (2011)

The conserved dileucine- and tyrosine-based motifs in MLV and MPMV envelope glycoproteins are both important to regulate a common Env intracellular trafficking
por: Blot, Vincent, et al.
Publicado: (2006)

Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
por: Trinité, Benjamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fh6n1hv9l13ucjh7b86sq41blq